Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Improved diagnostic tests for tuberculosis in children are needed. We hypothesized that transcriptional signatures of host blood could be used to distinguish tuberculosis from other diseases in African children who either were or were not infected with the human immunodeficiency virus (HIV). METHODS: The study population comprised prospective cohorts of children who were undergoing evaluation for suspected tuberculosis in South Africa (655 children), Malawi (701 children), and Kenya (1599 children). Patients were assigned to groups according to whether the diagnosis was culture-confirmed tuberculosis, culture-negative tuberculosis, diseases other than tuberculosis, or latent tuberculosis infection. Diagnostic signatures distinguishing tuberculosis from other diseases and from latent tuberculosis infection were identified from genomewide analysis of RNA expression in host blood. RESULTS: We identified a 51-transcript signature distinguishing tuberculosis from other diseases in the South African and Malawian children (the discovery cohort). In the Kenyan children (the validation cohort), a risk score based on the signature for tuberculosis and for diseases other than tuberculosis showed a sensitivity of 82.9% (95% confidence interval [CI], 68.6 to 94.3) and a specificity of 83.6% (95% CI, 74.6 to 92.7) for the diagnosis of culture-confirmed tuberculosis. Among patients with cultures negative for Mycobacterium tuberculosis who were treated for tuberculosis (those with highly probable, probable, or possible cases of tuberculosis), the estimated sensitivity was 62.5 to 82.3%, 42.1 to 80.8%, and 35.3 to 79.6%, respectively, for different estimates of actual tuberculosis in the groups. In comparison, the sensitivity of the Xpert MTB/RIF assay for molecular detection of M. tuberculosis DNA in cases of culture-confirmed tuberculosis was 54.3% (95% CI, 37.1 to 68.6), and the sensitivity in highly probable, probable, or possible cases was an estimated 25.0 to 35.7%, 5.3 to 13.3%, and 0%, respectively; the specificity of the assay was 100%. CONCLUSIONS: RNA expression signatures provided data that helped distinguish tuberculosis from other diseases in African children with and those without HIV infection. (Funded by the European Union Action for Diseases of Poverty Program and others).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Panels containing a limited number of host biomarkers are being developed as diagnostic assays for influenza77, tuberculosis70 and bacterial sepsis78.”
From Clinical metagenomics (2019) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationPerez-Velez, C. M., & Marais, B. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1008049 · Cited by 572
Zar, H. J., Hanslo, D., Apolles, P., Swingler, G., & Hussey, G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17702-2 · Cited by 511
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Wallis, R. S., Pai, M., Menzies, D., Doherty, T. M., Walzl, G., Perkins, M. D., & Zumla, A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-5 · Cited by 453
Kaforou, M., Wright, V. J., Oni, T., French, N., Anderson, S. T., Bangani, N., Banwell, C. M., Brent, A. J., Crampin, A. C., Dockrell, H. M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001538 · Cited by 371
Self-citationNicol, M. P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Boehme, C. C., Zemanay, W., & Zar, H. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70167-0 · Cited by 338
Self-citationChintu, C., Mudenda, V., Lucas, S., Nunn, A., Lishimpi, K., Maswahu, D., Kasolo, F., Mwaba, P., Bhat, G., Terunuma, H., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11082-8 · Cited by 333
Graham, S. M., Ahmed, T., Amanullah, F., Browning, R., Cardenas, V., Casenghi, M., Cuevas, L. E., Gale, M., Gie, R. P., Grzemska, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis008 · Cited by 325
Cited by
Items 101–200 of 384
Burel, J. G., Babor, M., Pomaznoy, M., Arlehamn, C. S. L., Khan, N. A., Sette, A., & Peters, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00221 · Cited by 50
“Importantly, all these signatures were not significantly distorted by HIV infection status (22, 44).”
BackgroundInfluentialDiagnosis of childhood febrile illness using a multi-class blood RNA molecular signature
Habgood-Coote, D., Wilson, C., Shimizu, C., Barendregt, A. M., Philipsen, R. L. A., Galassini, R., Calle, I. R., Workman, L., Agyeman, P., Ferwerda, G., et al. (2023) · Med · doi:10.1016/j.medj.2023.06.007 · Cited by 54
Self-citationBah, S. Y., Morang’a, C. M., Kengne-Ouafo, J. A., Amenga-Etego, L. N.-K., & Awandare, G. A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00575 · Cited by 49
Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility
Ssekamatte, P., Sande, O. J., van Crevel, R., & Biraro, I. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122255 · Cited by 55
Aketi, L. P., Kashongwe, Z. M., Kinsiona, C., Fueza, S. B., Kokolomami, J. H. T., Bolie, G., Lumbala, P. K., & Diayisu, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153914 · Cited by 45
Clinical Immunology and Multiplex Biomarkers of Human TuberculosisPreprint
Walzl, G., Haks, M. C., Joosten, S. A., Kleynhans, L., Ronacher, K., & Ottenhoff, T. H. M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018515 · Cited by 45
Self-citationWobudeya, E., Bonnet, M., Walters, E. G., Nabeta, P., Song, R., Murithi, W. B., Mchembere, W., Dim, B., Taguebue, J.-V., Orne‐Gliemann, J., et al. (2022) · Pathogens · doi:10.3390/pathogens11040389 · Cited by 59
“Performance of first gene expression signatures on a large number of genes had limited but promising performance for the diagnosis of childhood TB, notably in those without microbiological confirmation [92].”
BackgroundPediatric Tuberculosis Diagnostics: Present and Future
Basile, F. W., Nabeta, P., Rühwald, M., & Song, R. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac082 · Cited by 49
Hamada, Y., Penn‐Nicholson, A., Krishnan, S., Cirillo, D. M., Matteelli, A., Wyss, R., Denkinger, C. M., Rangaka, M. X., Rühwald, M., & Schumacher, S. G. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104174 · Cited by 44
Genomics of Human Pulmonary Tuberculosis: from Genes to Pathways
Stein, C. M., Sausville, L. N., Wejse, C. M., Sobota, R. S., Zetola, N. M., Hill, P. C., Boom, W. H., Scott, W. K., Sirugo, G., & Williams, S. M. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0130-9 · Cited by 43
Choudhary, R. K., Wall, K. M., Njuguna, I. N., Pavlinac, P. B., LaCourse, S. M., Otieno, V. O., Gatimu, J., Stern, J., Maleche‐Obimbo, E., Wamalwa, D. C., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001893 · Cited by 39
KASS, N. E., Faden, R., FABI, R. E., Morain, S. R., Hallez, K., Whicher, D. M., Tunis, S., Moloney, R., Messner, D. A., & Pitcavage, J. M. (2016) · AJOB Empirical Bioethics · doi:10.1080/23294515.2016.1156188 · Cited by 40
Transcriptomics for child and adolescent tuberculosis*
Kaforou, M., Broderick, C. M., Vito, O., Levin, M., Scriba, T. J., & Seddon, J. A. (2022) · Immunological Reviews · doi:10.1111/imr.13116 · Cited by 62
“Data presented in Figures 5-9 are publically available in Anderson et al [99].”
MethodInfluentialSelf-citationDiagnostic value of blood gene expression signatures in active tuberculosis in Thais: a pilot study
Satproedprai, N., Wichukchinda, N., Suphankong, S., Inunchot, W., Kuntima, T., Kumperasart, S., Wattanapokayakit, S., Nedsuwan, S., Yanai, H., Higuchi, K., et al. (2015) · Genes and Immunity · doi:10.1038/gene.2015.4 · Cited by 36
Wang, S., He, L., Wu, J., Zhou, Z., Gao, Y., Chen, J., Shao, L., Zhang, Y., & Zhang, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02948 · Cited by 37
“Several transcriptional signatures have been proposed as diagnostic biomarkers for ATB by other studies (19, 25, 27, 28).”
MethodA systematic approach to diagnosing intra-thoracic tuberculosis in children
Pérez‐Vélez, C. M., Pabón, C. L. R., & Marais, B. J. (2017) · Journal of Infection · doi:10.1016/s0163-4453(17)30195-0 · Cited by 37
Transformative tools for tackling tuberculosis
Gardiner, J. L., & Karp, C. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151468 · Cited by 41
“Unbiased transcriptional profiling has also been applied to the development of a diagnostic test for childhood TB (Anderson et al., 2014).”
MethodHuman genetics of mycobacterial disease
Dallmann-Sauer, M., Correa-Macedo, W., & Schurr, E. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9765-4 · Cited by 36
Tientcheu, L. D., Maertzdorf, J., Weiner, J. M., Adetifa, I., Mollenkopf, H., Sutherland, J. S., Donkor, S. A., Kampmann, B., Kaufmann, S. H. E., Dockrell, H. M., et al. (2015) · Genes and Immunity · doi:10.1038/gene.2015.21 · Cited by 40
Self-citationTió‐Coma, M., van Hooij, A., Bobosha, K., Schip, J. J. V. D. P.-V., Banu, S., Khadge, S., Thapa, P., Kunwar, C. B., Goulart, I. M. B., Bekele, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54213-y · Cited by 40
Self-citationWhole transcriptomic network analysis using Co-expression Differential Network Analysis (CoDiNA)
Gysi, D. M., Fragoso, T. D. M., Zebardast, F., Bertoli, W., Busskamp, V., Almaas, E., & Nowick, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240523 · Cited by 39
“Both studies are available at GEO; the first one (GSE39941 [40]) contains gene expression data from 192 children with TB from Kenya, South Africa and from Malawi (HIV n = 69, HIV n = 123); the second one (GSE37250 [41]) contains expression data from 197 adults with TB from South Africa and Malawi (HIV n = 99, HIV n =…”
BackgroundBiomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review
Leo, S., Narasimhan, M., Rathinam, S., & Banerjee, A. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2386030 · Cited by 40
“The researchers then compared these transcript profiles with those of children diagnosed with LTBI as well as other disorders [61].”
ResultLubbers, R., Sutherland, J. S., Goletti, D., de Paus, R. A., Dijkstra, D. J., van Moorsel, C. H. M., Veltkamp, M., Vestjens, S. M. T., Bos, W. J. W., Petrone, L., et al. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.02.006 · Cited by 35
Self-citationTogun, T. O., Hoggart, C., Agbla, S. C., Gomez, M. P., Egere, U., Sillah, A. K., Saidy, B., Mendy, F. S., Pai, M., & Kampmann, B. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102909 · Cited by 35
Childhood tuberculosis: a concern of the modern world
Hamzaoui, A., Yaalaoui, S., Cherif, F. T., Saidi, L. S., & Berraïes, A. (2014) · European Respiratory Review · doi:10.1183/09059180.00005314 · Cited by 42
Jenum, S., Sivakumaran, D., Lodha, R., Mukherjee, A., Saini, D. K., Singh, S., Singh, V., Medigeshi, G. R., Haks, M. C., Ottenhoff, T. H. M., et al. (2016) · Scientific Reports · doi:10.1038/srep18520 · Cited by 33
Self-citationAdvances in the diagnosis of pulmonary tuberculosis in children
Nicol, M. P., & Zar, H. J. (2020) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2020.05.003 · Cited by 42
Guinn, K. M., & Rubin, E. J. (2017) · mBio · doi:10.1128/mbio.01910-17 · Cited by 40
Perumal, P., Abdullatif, M. B., Garlant, H. N., Honeyborne, I., Lipman, M. C. I., McHugh, T. D., Southern, J., Breen, R. A. M., Santis, G., Ellappan, K., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612564 · Cited by 39
Nicol, M. P., Gnanashanmugam, D., Browning, R., Click, E. S., Cuevas, L. E., Detjen, A., Graham, S. M., Levin, M., Makhene, M., Nahid, P., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ613 · Cited by 34
“tuberculosis has been isolated from a variety of respiratory and alimentary tract specimens, and potential diagnostic biomarkers can also be detected in blood products and urine [7, 8, 21, 25–28].”
BackgroundSelf-citationNeuter, N. D., Bartholomeus, E., Elias, G., Keersmaekers, N., Suls, A., Jansens, H., Smits, E., Hens, N., Beutels, P., Damme, P. V., et al. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0035-y · Cited by 33
Petrilli, J. D., Araújo, L. E., da Silva, L. S., Laus, A. C., Müller, I., Reis, R. M., Netto, E. M., Riley, L. W., Arruda, S. M., & Queiroz, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-78793-2 · Cited by 30
Searching for a technology-driven acute rheumatic fever test: the START study protocol
Ralph, A. P., Webb, R., Moreland, N. J., McGregor, R., Bosco, A., Broadhurst, D., Lassmann, T., Barnett, T. C., Ben-Othman, R., Yan, J., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053720 · Cited by 31
“Participants will have blood collected for comprehensive immune profiling.”
MethodExpression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis
Qian, Z., Lv, J., Kelly, G. T., Wang, H., Zhang, X., Gu, W., Yin, X., Wang, T., & Zhou, T. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.04.008 · Cited by 27
Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection
Huaman, M. A., Deepe, G. S., & Fichtenbaum, C. J. (2016) · Pathogens and Immunity · doi:10.20411/pai.v1i2.149 · Cited by 29
“The interferon module included genes involved in type 1 and type 2 interferon responses [21-25].”
BackgroundImmunological Aspects of Diagnosis and Management of Childhood Tuberculosis
Gutiérrez-González, L. H., Juárez, E., Carranza, C., Carreto-Binaghi, L. E., Alejandre, A., Cabello-Gutiérrrez, C., & González, Y. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s295798 · Cited by 37
"Targeted" Consent for Pragmatic Clinical Trials
Wendler, D. S. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3169-2 · Cited by 29
Towards new TB vaccines: What are the challenges?
Dockrell, H. M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw016 · Cited by 33
Self-citationThe potential of digital molecular diagnostics for infectious diseases in sub-Saharan Africa
The Digital Diagnostics for Africa Network (2022) · PLOS Digital Health · doi:10.1371/journal.pdig.0000064 · Cited by 35
“Evolving approaches to diagnosis based on integration of quantitative data from multiple analytes, such as disease risk scores using gene expression levels [65,74], could easily be implemented in digital diagnostics.”
Molecular Diagnosis of TB in the HIV Positive Population
Vittor, A. Y., Garland, J. M., & Gilman, R. H. (2015) · Annals of Global Health · doi:10.1016/j.aogh.2015.01.001 · Cited by 31
Addressing the risk domain in the long‐term management of pediatric asthma
Hamelmann, E. H., von Mutius, E., Bush, A., & Szefler, S. J. (2019) · Pediatric Allergy and Immunology · doi:10.1111/pai.13175 · Cited by 32
Barral‐Arca, R., Gómez‐Carballa, A., Cebey‐López, M., Bello, X., Martinón‐Torres, F., & Salas, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051831 · Cited by 32
Regulatory T Cells and Pro-inflammatory Responses Predominate in Children with Tuberculosis
Whittaker, E., Nicol, M. P., Zar, H. J., & Kampmann, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00448 · Cited by 26
Diagnostic host gene signature for distinguishing enteric fever from other febrile diseases
Blohmke, C. J., Müller, J., Gibani, M. M., Dobinson, H., Shrestha, S., Perinparajah, S., Jin, C., Hughes, H., Blackwell, L., Dongol, S., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910431 · Cited by 29
“…identified from samples collected in high-incidence, disease-endemic settings and been further validated against other disease processes including (but not limited to) pneumonia, sepsis, and streptococcal and staphylococcal infections (Berry et al, 2010a; Anderson et al, 2014; Sweeney et al, 2016).”
BackgroundSivakumaran, D., Ritz, C., Gjøen, J. E., Vaz, M. A. P., Selvam, S., Ottenhoff, T. H. M., Doherty, T. M., Jenum, S., & Grewal, H. M. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.626049 · Cited by 26
“Previous studies have identified different transcript signatures for distinguishing TB from latent TB and other diseases in Malawian and South African pediatric (35) and adult (14)”
BackgroundSelf-citationOlbrich, L., Nliwasa, M., Sabi, I., Ntinginya, N. E., Khosa, C., Banze, D., Corbett, E. L., Semphere, R., Verghese, V. P., Michael, J. S., et al. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003853 · Cited by 27
Thomas, T. A. (2018) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2018.09.009 · Cited by 33
Mansury, D., Ghazvini, K., Jamehdar, S. A., Badiee, A., Tafaghodi, M., Nikpoor, A. R., Amini, Y., & Jaafari, M. R. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1557674 · Cited by 28
“Bacillus Calmette-Guerin (BCG) has been used since 1921 and is still prescribed for the vaccination of infants in most countries [3].”
MethodTornheim, J. A., Madugundu, A. K., Paradkar, M., Fukutani, K. F., Queiroz, A. T. L., Gupte, N., Gupte, A., Kinikar, A. A., Kulkarni, V., Balasubramanian, U., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz639 · Cited by 35
“We assessed the performance of our gene lists in those 3 studies, as well as a large pediatric dataset [7] and 3 studies of treatment response (Figure 4, Table 2) [10, 15, 24].”
BackgroundMethodWhole-Blood Gene Expression Profile After Hypoxic-Ischemic Encephalopathy
Montaldo, P., Burgod, C., Herberg, J. A., Kaforou, M., Cunnington, A. J., Mejías, A., Cirillo, G., del Giudice, E. M., Capristo, C., Bandiya, P., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.54433 · Cited by 25
Self-citationGetting it right for children: improving tuberculosis treatment access and new treatment options.
Brigden, G., Furin, J. J., van Gulik, C., & Marais, B. J. (2015) · PubMed · doi:10.1586/14787210.2015.1015991 · Cited by 25
“There are promising developments with exploration of highly sophisticated new diagnostic approaches [69,70], ageappropriate PK studies to establish optimal drug doses in relevant age groups and inclusion of children in new TB treatment trials, including the treatment of MDR-TB.”
BackgroundKabir, S., Uddin, M. K. M., Chisti, M. J., Fannana, T., Haque, M. E., Uddin, M. R., Banu, S., & Ahmed, T. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.015 · Cited by 28
Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA
van Rensburg, I. C., Wagman, C., Stanley, K., Beltran, C. G. G., Ronacher, K., Walzl, G., & Loxton, A. G. (2016) · Oncotarget · doi:10.18632/oncotarget.12184 · Cited by 25
Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study
Muwanga, V. M., Mendelsohn, S. C., Leukes, V., Stanley, K., Mbandi, S. K., Erasmus, M., Flinn, M., Fisher, T.-L., Raphela, R., Bilek, N., et al. (2024) · European Respiratory Journal · doi:10.1183/13993003.00153-2024 · Cited by 34
“…of the signatures evaluated here, alongside many others not included, have either been developed or validated predominantly in South African populations [9, 31, 35, 37, 41, 42] or using publicly available datasets [31, 32, 46, 60] generated from studies conducted within South Africa [7, 8, 10, 12].”
MethodLipids as Biomarkers of Cancer and Bacterial Infections
Larrouy-Maumus, G. J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180904120029 · Cited by 23
Bah, S. Y., Forster, T., Dickinson, P., Kampmann, B., & Ghazal, P. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00457 · Cited by 22
Duffy, F. J., Thompson, E. G., Scriba, T. J., & Zak, D. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219322 · Cited by 27
“many previous studies[9–12], but these signatures are generally focused on a single binary 77 comparison, e.”
BackgroundChallenges in childhood tuberculosis
Swaminathan, S., & Ramachandran, G. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.175 · Cited by 24
Pang, J., Lindblom, A., Tolfvenstam, T., Thein, T.-L., Naim, A. N. M., Ling, L., Chow, A. Y., Chen, M. I.-C., Ooi, E. E., Leo, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155993 · Cited by 26
Self-citationComparing tuberculosis gene signatures in malnourished individuals using the TBSignatureProfiler
Johnson, W. E., Odom-Mabey, A. R., Cintron, C., Muthaiah, M., Knudsen, S., Joseph, N. M., Babu, S. P., Lakshminarayanan, S., Jenkins, D. F., Zhao, Y., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-020-05598-z · Cited by 32
“In addition, several of our signature gene sets were trained in pediatric cohorts [13, 72], but Johnson et al.”
BackgroundA Two-Gene Signature for Tuberculosis Diagnosis in Persons With Advanced HIV
Kulkarni, V., Queiroz, A. T. L., Sangle, S., Kagal, A., Salvi, S., Gupta, A., Ellner, J. J., Kadam, D., Rolla, V. C., Andrade, B. B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631165 · Cited by 25
“The second study identified and validated transcriptomic signatures to distinguish active TB from other respiratory diseases as well as LTBI among large pediatric cohorts from South Africa, Malawi and Kenya (29); the comparison for validation was TB-HIV vs. HIV and other respiratory diseases.”
BackgroundInfluentialGong, Z. H., Gu, Y., Xiong, K., Niu, J., Zheng, R., Su, B., Fan, L., & Xie, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.650567 · Cited by 24
A diagnostic classifier for gene expression-based identification of early Lyme disease
Servellita, V., Bouquet, J., Rebman, A. W., Yang, T., Samayoa, E., Miller, S. A., Stone, M., Lanteri, M. C., Busch, M. P., Tang, P., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00127-2 · Cited by 25
A blood RNA transcriptome signature for COVID-19
Kwan, P. K. W., Cross, G. B., Naftalin, C. M., Ahidjo, B. A., Mok, C. K., Fanusi, F., Sari, I. P., Chia, S. C., Kumar, S. K., Alagha, R., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01006-w · Cited by 23
Self-citationZafari, P., Golpour, M., Hafezi, N., Bashash, D., Esmaeili, S., Tavakolinia, N., & Rafiei, A. (2020) · IUBMB Life · doi:10.1002/iub.2413 · Cited by 24
Jackson, H., Miglietta, L., Habgood-Coote, D., D’Souza, G., Shah, P., Nichols, S. J., Vito, O., Powell, O., Davidson, M. S., Shimizu, C., et al. (2023) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piad035 · Cited by 23
Self-citationVargas, R., Abbott, L. E., Bower, D., Frahm, N., Shaffer, M., & Yu, W. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010770 · Cited by 22
Hemingway, C. A., Berk, M., Anderson, S. T. B., Wright, V., Hamilton, S., Eleftherohorinou, H., Kaforou, M., Goldgof, G. M., Hickman, K., Kampmann, B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185973 · Cited by 25
Self-citationMartinón‐Torres, F., Bosch, F. X., Rappuoli, R., Ladhani, S. N., Redondo, E., Vesikari, T., García‐Sastre, A., Calle, I. R., Rial, J. G., Salas, A., et al. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1609823 · Cited by 21
A blood RNA transcript signature for TB exposure in household contacts
Kwan, P. K. W., Periaswamy, B., de Sessions, P. F., Lin, W., Molton, J. S., Naftalin, C. M., Naim, A. N. M., Hibberd, M. L., & Paton, N. I. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05116-1 · Cited by 21
Self-citationKasule, G. W., Hermans, S., Semugenze, D., Wekiya, E., Kikoyo, J. N., Mwachan, P., Kabugo, J., Joloba, M. L., García‐Basteiro, A. L., Ssengooba, W., et al. (2024) · European journal of medical research · doi:10.1186/s40001-024-02092-z · Cited by 24
“Some which have been documented include; age, nutritional status especially in children, PLHIV [113, 114] environment [81], pre-analytical activities (location of sampling, collection method, differences in swab collection sites, time and frequency of sampling, sample processing for example oral…”
BackgroundHuman Genomics of Mycobacterium tuberculosis Infection and Disease
Orlova, M., & Schurr, E. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0124-7 · Cited by 21
Robustifying genomic classifiers to batch effects via ensemble learning
Zhang, Y., Patil, P., Johnson, W. E., & Parmigiani, G. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa986 · Cited by 18
Tricks to translating TB transcriptomics.
Deffur, A., Wilkinson, R. J., & Coussens, A. K. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.04.12 · Cited by 19
“org Figure 1 Human sample types and patient group classification criteria in studies publishing novel TB transcriptomic data (2-16).”
BackgroundSelf-citationFaddoul, D. (2015) · Advances in Pediatrics · doi:10.1016/j.yapd.2015.04.001 · Cited by 25
Li, B., Tan, Q., Fan, Z., Xiao, K., & Liao, Y. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900189 · Cited by 19
Rhedin, S., Elfving, K., & Berggren, A. (2021) · Children · doi:10.3390/children8111070 · Cited by 27
Transcriptomics: The Key to Biomarker Discovery During Tuberculosis?
van Rensburg, I. C., & Loxton, A. G. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.16 · Cited by 20
Tsalik, E. L., Li, Y., Hudson, L. L., Chu, V. H. Y., Himmel, T. L., Limkakeng, A. T., Katz, J. N., Glickman, S. W., McClain, M. T., Welty‐Wolf, K. E., et al. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201504-205oc · Cited by 20
Tuberculosis Diagnostics: State of the Art and Future Directions
Pai, M., Nicol, M. P., & Boehme, C. C. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch16 · Cited by 22
Host RNA signatures for diagnostics: An example from paediatric tuberculosis in Africa
Kaforou, M., Wright, V., & Levin, M. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.08.006 · Cited by 20
Self-citationTeste rápido molecular GeneXpert MTB/RIF para diagnóstico da tuberculose
Maschio-Lima, T., Belotti, N. C. U., Nardi, S. M. T., & Pedro, H. D. S. P. (2017) · Revista Pan-Amazônica de Saúde · doi:10.5123/s2176-62232017000200008 · Cited by 46
Ho, J., Bokil, N. J., Nguyen, P. T. B., Nguyen, T. A., Liu, M. Y., Hare, N. J., Fox, G. J., Saunders, B. M., Marks, G. B., & Britton, W. J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.066 · Cited by 18
Pediatric Tuberculosis: The Impact of “Omics” on Diagnostics Development
Jakhar, S., Bitzer, A. A., Stromberg, L. R., & Mukundan, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196979 · Cited by 20
Broderick, C. M., Cliff, J. M., Lee, J., Kaforou, M., & Moore, D. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102033 · Cited by 20
Self-citationCintron, C., Narasimhan, P. B., Locks, L. M., Babu, S. P., Sinha, P., Rajkumari, N., Kaipilyawar, V., Bhargava, A., Maloomian, K., Chandrasekaran, P., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06734-z · Cited by 21
Bedell, R., van Lettow, M., Meaney, C. A., Corbett, E. L., Chan, A. K., Heyderman, R. S., Anderson, S. T. B., Åkesson, A., Kumwenda, M., Zachariah, R., et al. (2017) · Tropical Medicine & International Health · doi:10.1111/tmi.13025 · Cited by 17
Self-citationVessière, A., Font, H., Gabillard, D., Adonis-Koffy, L. Y., Borand, L., Chabala, C., Khosa, C., Mavale, S., Moh, R., Mulenga, V., et al. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02576-5 · Cited by 18
Tuberculosis in the African continent: A comprehensive review
Chatterjee, D., & Pramanik, A. K. (2015) · Pathophysiology · doi:10.1016/j.pathophys.2014.12.005 · Cited by 17
Use of gene expression studies to investigate the human immunological response to malaria infection
Hodgson, S. H. C., Müller, J., Lockstone, H. E., Hill, A. V. S., Marsh, K., Draper, S. J., & Knight, J. C. (2019) · Malaria Journal · doi:10.1186/s12936-019-3035-0 · Cited by 19
Performance of metabonomic serum analysis for diagnostics in paediatric tuberculosis
Andreas, N. J., Roy, R. B., Gómez‐Romero, M., der Sluis, V. H.-V., Lewis, M. R., Camuzeaux, S., Jiménez, B., Posma, J. M., Tientcheu, L. D., Egere, U., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64413-6 · Cited by 17
Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.056 · Cited by 19
“Most of these vaccine candidates are subunit vaccines, where selected Mtb antigens are expressed in recombinant viral vectors or are administered as protein/adjuvant combinations [5].”
BackgroundTranscriptomic profile of adverse neurodevelopmental outcomes after neonatal encephalopathy
Montaldo, P., Cunnington, A. J., Oliveira, V., Swamy, R. S., Bandya, P., Pant, S., Lally, P., Ivain, P., Mendoza, J., Atreja, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70131-w · Cited by 17
Self-citationO’Connor, D., Pinto, M. V., Sheerin, D., Tomić, A., Drury, R. E., Channon‐Wells, S., Galal, U., Dold, C., Robinson, H., Kerridge, S. A., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20209888 · Cited by 18
“Recent reports have shown the power of peripheral blood RNA signatures in discerning the aetiology of acute febrile illness in children (Kaforou et al, 2013; Anderson et al, 2014; Herberg et al, 2016; Mahajan et al, 2016; Wright et al, 2018).”
BackgroundSelf-citationMonocyte-related gene biomarkers for latent and active tuberculosis
Li, Y., Deng, Y., & He, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.2003931 · Cited by 18
“Four independent datasets (GSE19444 [20], GSE37250 [21], GSE39939 [22], and GSE39940 [22] (see Supplementary Table 1) were used to validate the DEMonRGs between latent and active TB.”
MethodTuberculosis infection screening in children with close contact: a hospital-based study
Sun, L., Qi, X., Guo, Y., Qi, H., Li, J., Wu, X., Yin, Q.-Q., Guo, Y., Xu, B., Wang, Y., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06480-2 · Cited by 18
“Several host response-based transcriptional signatures have been described for anticipating progression from latent to active disease [21, 22]; however, multicohort studies are needed to validate the value of these when translated to clinical practice.”
BackgroundTeklu, T., Kwon, K., Wondale, B., Hailemariam, M., Zewude, A., Medhin, G., Legesse, M., Pieper, R., & Ameni, G. (2018) · Infection and Immunity · doi:10.1128/iai.00759-17 · Cited by 15
“Though transcriptional signatures can distinguish active TB from LTBI (23, 24) and further predict progression of LTBI to active TB (25), translating these signatures into tests for diagnosis is challenging anywhere, but especially in resource-poor settings.”
BackgroundBaguma, R., Mbandi, S. K., Rodo, M., Erasmus, M., Day, J., Makhethe, L., de Kock, M., van Rooyen, M., Stone, L., Bilek, N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639965 · Cited by 19
“Previously published microarray data from children aged 4– 12 years and adults with microbiologically-confirmed TB or LTBI controls were processed in the same facility and run on Illumina HT12 beadarrays: GSE39940 and GSE37250 (19, 20).”
BackgroundMethodAssessing the risk of TB progression: Advances in blood-based biomarker research
Li, Z., Hu, Y., Zou, F., Gao, W., Feng, S., Chen, G., Yang, J., Wang, W., Shi, C., Cai, Y., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.128038 · Cited by 14
Molecular diagnosis: Implications for ophthalmology
Rosenbaum, J. T., Sibley, C. H., Choi, D., Harrington, C. A., & Planck, S. R. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.11.001 · Cited by 14
“Although we have not attempted this comparison, a group has studied whole blood profiling of children in Africa and reported that this technology accurately recognizes active tuberculosis (Anderson et al., 2014).”
Metadata
- Authors
- Anderson, S. T., Kaforou, M., Brent, A. J., Wright, V. J., Banwell, C. M., Chagaluka, G., Crampin, A. C., Dockrell, H. M., French, N., Hamilton, M. S., Hibberd, M. L., Kern, F., Langford, P. R., Ling, L., Mlotha, R., Ottenhoff, T. H. M., Pienaar, S., Pillay, V., Scott, J. A. G., Twahir, H., Wilkinson, R. J., Coin, L. J., Heyderman, R. S., Levin, M., & Eley, B.
- Affiliations
- Brighton and Sussex Medical School (GB)
- Imperial College London (GB)
- Kenya Medical Research Institute (KE)
- Wellcome Trust (GB)
- University of Malawi (MW)
- University of Liverpool (GB)
- Genome Institute of Singapore (SG)
- Leiden University Medical Center (NL)
- Red Cross War Memorial Children's Hospital (ZA)
- Institute of Infectious Disease and Molecular Medicine (ZA)
- The University of Queensland (AU)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-05
- Volume
- 370
- Issue
- 18
- Pages
- 1712-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4069985
- OpenAlex
- W2145559868
- Cited by
- 379
- References
- 36
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 33 · 2023: 28 · 2022: 27 · 2021: 35 · 2020: 35 · 2019: 31 · 2018: 40 · 2017: 29 · 2016: 37 · 2015: 46 · 2014: 8
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Wellcome Trust (101113, 088316, 077092, 104803/Z/14/Z, 084679, 081697, 100714, 092654, 100890, 098532/B/12/Z, 098532, 84323, 081835, 084323)
- National Institute for Health and Care Research (NF-SI-0611-10230)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- pediatric tuberculosis, tuberculosis diagnosis, blood transcriptome, latent tuberculosis infection, HIV coinfection, culture-negative tuberculosis, Xpert MTB/RIF, sensitivity and specificity, African children
- MeSH terms
- Africa, Algorithms, Bacteriological Techniques, Child, Child, Preschool, Diagnosis, Differential, Humans, Infant, Male, Mycobacterium tuberculosis, Risk, RNA, Bacterial, Sensitivity and Specificity, Tuberculosis, HIV Infections, Oligonucleotide Array Sequence Analysis, Latent Tuberculosis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.